[Platelet rich plasma in musculoskeletal conditions]
Mengarelli C, Augustovski F, Alcaraz A,, Pichon-Riviere A, , García Martí S, Bardach A, Ciapponi A,
Record ID 32018001575
Spanish
Authors' recommendations:
Low-quality evidence on platelet-rich plasma supplementation during arthroscopic repair of completely torn rotator cuff suggests that it might mildly reduce pain and improve shoulder movement postoperatively at short and long term and it might be associated with a small reduction in re-tear probability. Low-quality evidence does not allow to determine the clinically relevant advantage of the use of platelet-rich plasma during arthroscopic repair of torn cruciate ligaments of the knee.
Low-quality evidence on platelet-rich plasma in patients with tendinopathy would suggest that it might mildly reduce pain at short term and it might result in a mild improvement in the joint function at long term in those who received other treatments.
The Canadian Agency for Drugs and Technologies in Health and the United Kingdom guidelines conclude that its effectiveness could not be determined since the evidence collected is heterogeneous and of low quality. Other clinical practice guidelines consulted do not mention or widely recommend its use.
No local economic evaluations have been found; therefore, the cost-effectiveness of plasma is unknown.
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Platelet-Rich Plasma
- Musculoskeletal Diseases
- Tendinopathy
- Shoulder Injuries
- Osteoarthritis, Knee
- Injections, Intra-Articular
- Rotator Cuff Injuries
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.